Abstracts - faqs.org

Abstracts

Law

Search abstracts:
Abstracts » Law

Mandatory disclosure as a solution to agency problems

Article Abstract:

Mandatory disclosure has evolved as a fundamental method for regulating securities because it addresses promoter problems and not because of the information that it provides to investors. Accuracy enhancement of investors is always cited as the reason for the disclosure system, but more efficient methods could be used to satisfy those concerns. The disclosure system should be seen in light of the agency cost model as a method for monitoring the activities of promoters more cost effectively. Among the revisions to disclosure requirements, self-dealing and executive compensation requirements have been the most important.

Author: Mahoney, Paul G.
Publisher: University of Chicago Law School
Publication Name: University of Chicago Law Review
Subject: Law
ISSN: 0041-9494
Year: 1995
Analysis, Disclosure (Securities law), Agency theory

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Physicians with AIDS: a proposal for efficient disclosure

Article Abstract:

Notification of former patients of physicians who die of HIV-related conditions should be done only when economically efficient. In other words, 'lookbacks' should be allowed or required only when the cost of accidents prevented multiplied by the probability of accidents occurring is greater than the cost of notification. The cost of the lookback includes such factors as loss of privacy, costs of discrimination based on disability, emotional distress, loss of consortium and systemic or social costs. The high cost of disclosure plus the low probability of transmission makes lookback inefficient in most cases.

Author: Hertz, Jennifer
Publisher: University of Chicago Law School
Publication Name: University of Chicago Law Review
Subject: Law
ISSN: 0041-9494
Year: 1992
Laws, regulations and rules, Physicians, Medical professions, AIDS (Disease), Disease reporting

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Financial derivatives and the costs of regulatory arbitrage

Article Abstract:

Possible regulation of derivatives should be based on the particular uses of the financial instruments involved and not on the presumption that all derivatives are inherently good or inherently bad. Some derivatives take advantage of regulatory arbitrage opportunities, and these transactions result in distortions and deadweight welfare losses. Other transactions can be justified on efficiency and stability grounds. Regulators should investigate these influences and also consider whether additional regulations can be justified on economic efficiency grounds.

Author: Partnoy, Frank
Publisher: University of Iowa Journal of Corporation Law
Publication Name: The Journal of Corporation Law
Subject: Law
ISSN: 0360-795X
Year: 1997
Derivatives (Financial instruments), Arbitrage

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Economic aspects, Securities law
Similar abstracts:
  • Abstracts: Some observations on rehabilitation and justice. Attitudes, social problems and reconvictions in the 'STOP' probation experiment
  • Abstracts: Mandatory Retirement Contributions and the Section 414(h)(2) 'Pick-Up' Provision - An Overlooked Windfall for Qualifying Public Employees
  • Abstracts: Government intervention versus disclosure: the evolution of capital market regulation in Israel. Competition in the European financial services industry: the free movement of capital versus the regulation of money laundering
  • Abstracts: Fighting fire with firefighters: a proposal for expert judges at the trial level. Court of Federal Claims: a case against reform
  • Abstracts: High-risk sexual behavior and failure to disclose HIV infection to sex partners: How do we respond? Re-building distribution networks to assure future microbicide access
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.